Debugging how Bacteria Manipulate the Immune Response  by Sansonetti, Philippe J. & Di Santo, James P.
Immunity
ReviewDebugging how Bacteria
Manipulate the Immune Response
Philippe J. Sansonetti1,2,* and James P. Di Santo3,4
1 Unite´ de Pathoge´nie Microbienne Mole´culaire
2 Unite´ INSERM 786
3 Unite´ Cytokines et De´veloppement Lymphoı¨de
4 Unite´ INSERM 668
Institut Pasteur, 28 Rue du Docteur Roux, 75724 Paris, Cedex 15, France
*Correspondence: psanson@pasteur.fr
DOI 10.1016/j.immuni.2007.02.004
Beyond the innate response that is elicited when tissues are infected, bacterial pathogens have
evolved strategies to subvert the immune response and ‘‘recalibrate’’ it both qualitatively and quan-
titatively, thereby achieving a balance consistent with the survival of both the microbe and its infected
host, a compromise that is likely the result of a long process of coevolution between pathogens and
their hosts. By collaboratively studying the mechanisms employed, microbiologists and immunolo-
gists are fostering development of a renewed approach of infectious diseases that is expected to pro-
vide useful new concepts and applications for their control. In addition, the molecular strategies
developed by bacteria to dampen immune mechanisms result from such strong and prolonged se-
lective pressure for survival that they may point to original mechanisms and targets to conceive novel
immunomodulatory, anti-inflammatory, and anti-infectious molecules.Introduction
Exposure to microbes maintains steady-state ‘‘physiolog-
ical inflammation’’ at mucosal surfaces, a clinically silent
situation preventing tissue invasion by commensal organ-
isms. This involves tightly controled activation and/or re-
lease of an array of effectors comprising humoral factors
such as antimicrobial peptides, lectins, lysozyme, phos-
pholipases, proteases, and complement in tissues. Epithe-
lial cells and dendritic cells (DCs) act as sentinels at muco-
sal surfaces and secrete chemokines that recruit, activate,
and regulate inflammatory infiltrates, including polymor-
phonuclear leukocytes (PMNs) transmigrating through
the epithelium, resident macrophages, recruited mono-
cytes, and a variety of lymphocytes such as intraepithelial
lymphocytes. These effectors participate in the innate re-
sponse to commensals under steady-state conditions,
a situation of tolerance that commensal organisms them-
selves actively maintain. Conversely, bacterial pathogens,
particularly those invading tissues after mucosal coloniza-
tion, disrupt the balance and cause overt inflammation
involving massive activation of the above-mentioned
humoral and cellular effectors. This stereotypic innate re-
sponse largely reflects the capacity of bacterial pathogens
to subvert mucosal barriers and proceed, thereby facilitat-
ing ‘‘delivery’’ of pathogen-associated molecular patterns
(PAMPs) and pathogen-specific virulence factors to their
cognate receptors. In front of this deleterious host re-
sponse, bacterial pathogens express a large array of viru-
lence factors that dampen and/or reorient both innate and
adaptive immune responses. This emerging field of im-
mune manipulation by bacteria is the topic of this review.
By studying the tools bacteria have acquired through an
evolutionary process driven by the need to deceive hostdefense mechanisms (Sansonetti, 2004), a promising
new interface in microbiology and immunology has
emerged with outstanding research potential.
Commensal Intestinal Flora: An Immunological
‘‘De´tente’’
Mammals, particularly humans, exhibit a dynamic rela-
tionship with environmental bacteria. Newborns rapidly
adapt to the bacterial flora that quickly populate the
skin, the oral and vaginal cavities, and the gastro-intestinal
tract. Bacterial density in the latter is particularly well con-
trolled, showing a strong gradient from the stomach to the
colon (where up to 1011 organisms per gram of stool, be-
longing to 500 to 1000 different—mostly anaerobic—spe-
cies are present), and tolerance to microbial PAMPs (such
as lipopolysaccharide [LPS]) appears very early in the
perinatal period (Lotz et al., 2006). Colonization of the
gut by commensals has a positive effect on the mamma-
lian host (Hooper and Gordon, 2001). They exert protec-
tive functions against potentially intrusive pathogens by
nutrient and receptor competition and by production of
antimicrobial factors such as colicins. They also exert
structural functions, such as strengthening the monolayer
of epithelial cells exposed to various injuries, and meta-
bolic functions by synthesizing vitamins, by providing
short-chain fatty acids as carbon source for colonic epi-
thelial cells, and by metabolizing dietary carcinogens.
The gut flora also influences gut development and mat-
uration of the mucosal and systemic immune systems
(Hooper, 2004; Kelly and Conway, 2005). Germ-free
mice not only show reduced expression of enterocytic
digestive enzymes, atrophic intestinal vasculature, and
enteric nervous system, they also show reducedImmunity 26, February 2007 ª2007 Elsevier Inc. 149
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smaller Peyer’s patches and lower numbers of intraepithe-
lial lymphocytes (Weinstein and Cebra, 1991), and of the
systemic immune system, with lower amounts of cyto-
kines and serum antibodies, particularly IgA. Reconstitu-
tion of the intestinal flora restores normal immune activa-
tion (Cebra, 1999; Shanahan, 2002). Commensal bacteria
also modulate the fine-tuning of T cell repertoires and reg-
ulate the differentiation of gut-resident T cells (that can
generate T helper 1 [Th1], Th2, Th17, and/or regulatory T
[Treg] cell phenotypes) (Weaver et al., 2006). This may in
turn act as a feedback mechanism to influence the diver-
sity and density of gut flora.
The bidirectional interaction betweeen the commensal
flora and the host immune system is based upon a com-
plex process of microbial sampling, integrated into an
even more complex network of microbial sensing leading
to the expression of soluble mediators (i.e., cytokines and
chemokines) that mobilize cellular effector mechanisms.
The sampling of commensal bacteria by gut-resident
DCs is increasingly understood. Three pathways have
been identified, including (1) autonomous epithelial trans-
location followed by macrophage killing, (2) passage via
specialized M cells, and (3) direct sampling by CX3CR1+
DCs. The result is processing of microbial material by
DCs that then travel to the mesenteric lymph nodes where
immune responses, in particular IgA, are induced (Mac-
pherson and Uhr, 2004). Mesenteric lymph nodes act as
gatekeepers preventing commensal bacteria access to
the systemic circulation. Our immune system therefore
seems to have been forged under two opposite con-
straints: necessity to resist attack by microbial pathogens,
balanced against need to maintain a benefical commensal
flora. Deciphering the paradox of the ‘‘immunological de´-
tente’’ in the intestine may provide insights into basic im-
munological mechanisms that apply outside of mucosal
tissues. The heightened susceptibility to inflammatory
bowel diseases (IBD), particularly Crohn’s disease (Hugot
et al., 2001; Ogura et al., 2001), in patients harboring mu-
tations in essential components of their bacterial recogni-
tion machinery is at the heart of this paradox and stresses
that human genetics play an increasingly important role in
the discovery process.
Understanding the above paradox will require answers
to two questions. First, how do microbes activate host-
sensing systems and how are recorded signals converted
to tolerance to commensals versus full-blown immune
response to pathogens? Second, do specific bacterial
components modulate these immunological responses,
at what stage do they do so, and on which cell targets
are they acting? Growing evidence indicates that com-
mensals actively dampen ‘‘physiological’’ inflammation
normally present in the gut. Inhibition of IkB degradation
is a preferred target, and manipulation of protein ubiquiti-
nation is a common theme. A nonpathogenic Salmonella
mutant inhibits the NF-kB signaling pathway by blocking
IkBa ubiquitination catalyzed by the E3-SCF (bTrCP) ubiq-
uitin ligase. E3 is regulated by covalent modification of its
Cullin-1 subunit by the ubiquitin-like protein NEDD8 (i.e.,150 Immunity 26, February 2007 ª2007 Elsevier Inc.neddylation). Rapid loss of neddylated Cul-1 blocks IkBa
degradation (Collier-Hyams et al., 2005). Bacteroides the-
taiotamicron targets the NF-kB subunit RelA, enhancing
its nuclear export through a mechanism independent of
the nuclear export receptor Crm-1. PPARg in complex
with RelA achieves its nuclear export, thereby suppress-
ing the transcription of NF-kB-induced proinflammatory
genes (Kelly et al., 2003). Lactobacillus casei induce tran-
scriptional downregulation of Roc-1 (i.e., subunit of E3-
SCF) and of several components of the proteasome,
thereby protecting IkBa from degradation (Tien et al.,
2006). The challenge is now to identify the effectors of
commensal microorganisms that actively manipulate in-
nate immunity, as recently done regarding Bacteroides
exopolysaccharides influencing maturation of the immune
sytem (Mazmanian et al., 2005).
Pattern recognition receptors (PRRs) on epithelial cells,
macrophages, and DCs are likely initiators of the immune
response to commensals, although the soluble mediators
they secrete under these conditions are not yet clearly
defined. DCs, after sampling luminal bacteria, migrate
to mesenteric lymph nodes and initiate an adaptive im-
mune response directing specific IgA production in the
lamina propria. Although the gut is often considered ‘‘im-
munologically suppressed,’’ this humoral response is the
most productive Ig pathway in the entire body and gener-
ates gram quantities of IgA each day (Fagarasan and
Honjo, 2003). This IgA-directed immune response (Fig-
ure 1) is mediated by local TGF-b production, resulting
in the suppression of alternative T cell differentiation pro-
grams, potentially through activation and maintenance of
natural CD25+ regulatory T cells (Chen et al., 2003). Other
specialized T cell subsets, including NKT cells and muco-
sal associated invariant T cells are also present in muco-
sal sites, accumulate in response to gut colonization by
commensal bacteria and may play a role in regulating
local IgA production (Treiner and Lantz, 2006). Initiation
of this response by Toll-like recepors (TLRs) appears to
maintain intestinal epithelial cell homeostasis (Rakoff-Na-
houm et al., 2004; Fukata et al., 2005), providing a mech-
anism by which commensals may impact on epithelial
barrier functions. Colonization by commensals alters
gut lymphocyte homeostasis and likely reduces the
threshold required for immune activation (Crabbe et al.,
1970). In contrast, immune mechanisms can shape bac-
terial load and diversity (Fagarasan et al., 2002). Never-
theless, despite an active adaptive response to commen-
sals, mice lacking adaptive lymphocytes (i.e., Rag-KO
mice) do not manifest overt intestinal pathologies, sug-
gesting that innate immune mechanisms are sufficient
to maintain the immunological de´tente with commensal
flora.
Pathogenic Flora: An All-Out War
Bacterial pathogens, unlike commensals, tip the immune
balance toward inflammation (Figure 2). By encoding fac-
tors that allow their adherence to and translocation
through epithelial barriers, pathogens show increased po-
tential for invasion and destruction of tissues, possibly
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secondary infectious foci and potentially severe sepsis
and septic shock. The latter reflect often irreversible loss
of control of the immune response, combined with exces-
sive production of amplification molecules such as pro-
teins of the TREM family (Colonna and Facchetti, 2003)
and HMGB1 (Lotze and Tracey, 2005). Moreover, the in-
flammatory response may also locally induce the opening
of barriers and further tissue destruction (Perdomo et al.,
1994a). Pathogen-induced inflammation occurs not only
in microbe-poor mucosal tissues (such as the respiratory
and genito-urinary tract or in the sterile environment of
host deep tissues) but also in mucosal areas otherwise
adapted to the constant presence of commensal micro-
bial flora, suggesting that immune regulatory mechanisms
that limit commensal invasion can be overruled by the
presence (or detection) of pathogenic microbes. Recently,
the proinflammatory Th17 cell subset has been identified
in the intestine (Ivanov et al., 2006). A combination of
TGF-b and IL-6 drives Th17 differentiation from naive T
cells, and Th17 T cells appear responsible for pathological
Figure 1. Physiological Inflammation
Physiological inflammation reflects a status of mucosal homeostasis
that includes tolerance to commensal bacteria, resulting in part to their
exclusion from mucosal surface by sIgA and other nonspecific defense
mechanisms (mucus, defensins, etc.). In general, epithelial barriers are
neither broken nor activated. Local TGF-b secretion drives regulatory
and helper Th2 cell differentiation (and limits Th1 and Th17 pathways),
thereby promoting IgA production. Specialized T cell subsets including
mucosal-associated invariant T cells (MAIT) may also be involved in
this process.inflammatory reactions in several disease models (Man-
gan et al., 2006; Yen et al., 2006). Interestingly, IL-6 can in-
hibit Treg cell differentiation in the presence of TGF-b (Bet-
telli et al., 2006), thereby providing a ‘‘cytokine switch’’
that could convert the ‘‘physiological inflammation’’ of
commensal IgA homeostasis into ‘‘pathological inflamma-
tion’’ observed with pathogenic microbes. Regulation of
IL-6 production may prove critical in tipping the balance
between ‘‘armed peace’’ and ‘‘all-out war’’ in the immune
response to intestinal bacteria.
In the presence of pathogens, the host response is am-
plified (Figure 2). It is marked by an intense inflammatory
response and consequently strong adaptive immune re-
sponse that completes the process of pathogen eradica-
tion and may allow for efficient protection (memory)
against subsequent infection by homologous microorgan-
isms. As such, it will come as no surprise that pathogenic
Figure 2. Pathological Inflammation
Pathological inflammation reflects a generic profile of innate immune
response to pathogen-associated molecular motifs (PAMP) after en-
gagement of pathogen-recognition receptors. Breaking of epithelial
barriers is associated with secretion of proinflammatory factors that re-
sult in recruitment of polymorphonuclear cells (PMN). Macrophage
and dendritic cell (DC) activation results in brisk production of cyto-
kines (IL-6, IL-12) that promote Th1 and Th17 differentiation and
suppress regulatory T cell function. An amplification loop reinforces
the inflammatory response resulting in PMN-mediated pathogen
(and tissue) destruction.Immunity 26, February 2007 ª2007 Elsevier Inc. 151
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mune response of their host. Evolution of pathogenic mi-
crobes has two intertwined consequences. First, modula-
tion of the stereotypic innate response in the course of an
infection should facilitate bacterial survival and thereby
subsequent colonization, infection, and dissemination to
additional hosts. Second, modulation of the adaptive re-
sponse (either as an indirect consequence of a modified
innate response or as a direct effect of microbial effectors
on adaptive lymphocytes) should diminish the capacity for
specific clonal recognition of a microorganism and thus
abolish immunological memory.
Pathogenic bacteria may use different and sometimes
opposite strategies to deceive the immune response of
the infected host. Some apply a stealth strategy to evade
detection at the earliest stages. Others confront innate
and adaptive defense mechanisms (Figure 3). As de-
scribed below, a large number of secreted effectors and
toxins that were until now considered to be molecular
agents able to cause cell and tissue lesions are actually
molecules that primarily affect immune responses. This
may occur through an array of effects such as resistance
to humoral defense mechanisms, interference with cyto-
kines and chemokine secretion, interference with antigen
presentation, inhibition of NK, B, and T cell functions, and
apoptosis of cells of the immune system.
Avoiding Pattern Recognition
Even though PAMPs (LPS, bacterial lipoproteins, peptido-
glycan, flagellin, CpG DNA, etc.) are shared by pathogenic
and nonpathogenic bacteria, one should recognize that
some signatures seem to characterize PAMPs from
pathogens. For instance, the lipid A from commensal
gram-negative microorganisms is generally pentacylated,
whereas the lipid A from enteric pathogens is hexacylated,
making the former poorly agonistic, if not antagonistic to
TLR4, and the latter strongly agonistic, thus proinflamma-
tory (Munford and Varley, 2006). This is possibly a mislead-
ing oversimplification. Some bacteria, like Shigella, pos-
sess an extra msbB gene on their virulence plasmid that
achieves full acylation of lipid A, thus significantly enhanc-
ing proinflammatory capacity to destroy the intestinal ep-
ithelium (D’Hauteville et al., 2002) and invade mucosal
tissues (Perdomo et al., 1994b). Conversely, several bac-
terial pathogens have developed strategies to downregu-
late their endotoxicity by reducing acylation of their lipid A.
Salmonella deacetylates its lipid A via PagL, a bacterial
deacetylase whose expression is under the control the
PhoP-PhoQ regulon (Kawasaki et al., 2004). Yersinia pes-
tis lipid A gets fully acylated at 30C, a temperature that is
not relevant to growth conditions in the human body,
whereas at the relevant temperature of 37C, its partial de-
acylation leads to significant loss of its agonistic effect on
TLR4 (Rebell et al., 2004). A genetically manipulated strain
expressing a hexacylated, TLR4-agonistic, lipid A at 37C
became avirulent, thereby overcoming the armentarium of
dedicated virulence factors. Interestingly, this avirulent
strain provides protection against challenge by a wild-
type Y. pestis (Montminy et al., 2006). The ability to ac-152 Immunity 26, February 2007 ª2007 Elsevier Inc.tively evade LPS-induced inflammation is therefore critical
for Y. pestis virulence. Evading TLR4 activation by lipid A
alteration contributes to the virulence of other gram-nega-
tive bacteria such as the dental pathogen Porphyromonas
gingivalis that expresses an array of agonistic and nona-
gonistic lipid A molecules (Darveau et al., 2004). Helico-
bacter pylori also accumulate pentacylated lipid A (Tran
et al., 2005) and a varying flagellin that is not agonist of
TLR5, a hiding property shared with Campylobacter jejuni
andBartonella bacilliformis (Andersen-Nissen et al., 2005).
One can anticipate that molecular signatures differ-
entiating PAMPs produced by pathogens from those
Figure 3. Subverted Inflammation
Subverted inflammation reflects the capacity of bacterial effectors
(toxins and other often injected proteins) to manipulate the generic
profile of innate immune response and thereby control inflammation.
This can result in decreased activation of NF-kB, decreased produc-
tion of inflammatory factors, and/or apoptosis of innate and adaptive
immune cells. Bacterial effectors can switch the macrophage and
DC cytokine production profile to increase IL-10 secretion, which en-
hances regulatory T cell differentiation. The immune subversion pro-
vides a better environment for survival and colonization of the bacteria
and results in inefficient adaptive immune responses. The immunolog-
ical balance is tipped towards a generalized weakening of Th1-Th2
responses and reoriented towards some level of immunological
tolerance.
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nized, including perhaps bacterial lipoproteins interacting
with TLR2 and peptidoglycan and muropeptides interact-
ing with intracellular Nod molecules. It should also be re-
emphasized that, like in Salmonella, these changes may
be transient and observed only under conditions corre-
sponding to certain stages in vivo. The poor induction of
the innate immune system by these stealth microorgan-
isms is clearly a field to be intensively explored in the
future, as it directly relates to opportunities to rationally
design better immunoadjuvants and vaccines.
Evading Death by PMNs
Bacterial pathogens have developed a wealth of diverse
mechanisms to avoid or antagonize the bactericidal po-
tential of effectors of the innate immune response. Poly-
morphonuclear (PMN) cells represent the first-line de-
fense against which gram-positive bacteria, for instance,
produce an array of enzymes and immunoregulatory mol-
ecules or ‘‘modulins’’ (reviewed in Foster, 2005).
ManyStaphylococcus aureus isolates secrete a chemo-
taxis inhibitor protein (CHIPS) that binds with high affinity
to the C5a receptor, and to the formyl peptides receptor
on neutrophils, thereby blocking engagement by their re-
spective agonists (De Haas et al., 2004). S. aureus isolates
also secrete a complement inhibitor (SCIN), a C3-conver-
tase inhibitor that blocks activation of complement on the
bacterial suface (Rooijakkers et al., 2005). CHIPS and
SCIN act as a countermeasure to block neutrophil attrac-
tion to the infection site. Streptococcus pyogenes causes
necrotizing fasciitis, a life-threatening infection in humans.
Infected subcutaneous tissues from patients and mice
challenged with the same strain show high bacterial loads
but striking paucity of infiltrating PMN cells. Impaired PMN
cell recruitment is attributed to degradation of IL-8 by
a streptococcal serine peptidase, ScpC (Hidalgo-Grass
et al., 2006). A major feature of pneumococcal pneumonia
is an abundant neutrophil infiltration. It was recently shown
that activated neutrophils release neutrophil extracellular
traps (NETs), which contain antimicrobial proteins bound
to a DNA scaffold. NETs provide a high local concentration
of antimicrobial factors killing microbes extracellularly
(Brinkmann et al., 2004). Pneumococci are trapped but,
unlike other pathogens, not killed by NETs. Expression
of a surface endonuclease, EndA, allows pneumococci
to degrade the DNA scaffold of NETs, escape, and spread
in tissues and bloodstream (Beiter et al., 2006).
Evading Death in Macrophages
The Type III secretory systems (TTSS) and their dedicated
secreted effectors were initially described to interact with
target cells subcortical actin cytoskeleton, thereby pro-
moting entry into epithelial cells in the case of Shigella
and Salmonella. We now know that other injected effec-
tors act at a different level, by altering phagocytic proper-
ties of macrophages, their killing capacities, or simply by
killing them. As such, TTSS effectors interfere with innate
defense mechanisms (Cornelis, 2006), thereby ‘‘carving’’the stereotypic response to bacterial PAMPs and generat-
ing a profile that represents a signature of the pathogen.
Yersinia spp. represent a paradigm of antiphagocytic
strategy. Their TTSS effectors, also called Yop proteins,
can be divided in two major groups (Navarro et al.,
2005): those that are essentially involved in preventing
phagocytosis by macrophages, and possibly other cellu-
lar effectors of the immune response, and those that
regulate the innate and adaptive response. Some Yops
belonging to the first category also regulate innate re-
sponses. The first group consists of (1) YopH, a protein
phosphatase that dephosphorylates FAK, p130Cas, Pax-
illin, FBP, and SKAP-HOM proteins that are essential in
the remodeling of the cell cytoskeleton, thereby strongly
interfering with cytoskeletal assembly at focal adhesions
and stress cables (Persson et al., 1997). It has also been
shown to inhibit the PI3K-Akt signaling pathway and pro-
duction of the MCP-1 chemokine, thereby possibly facili-
tating death of its target cells and downregulating recruit-
ment of proinflammatory cells (Sauvonnet et al., 2002). (2)
YopO/YpkA is a serine-threonine kinase that is activated
by cellular actin and plays a role in the disruption of target
cell cytoskeleton. Its C-terminal domain interacts with the
small GTPases RhoA and Rac1 (Juris et al., 2000). YopO/
YpkA possesses a Rac1-binding domain that mimics host
guanidine nucleotide dissociation inhibitors (GDIs) of the
Rho GTPases (Prehna et al., 2006). (3) YopT is a cysteine
protease that cleaves the Rho GTPases RhoA, Rac, and
Cdc42 in their C-terminal domain, causing their detach-
ment of the membrane, and arrest of Rho family signaling
to the cytoskeleton (Shao et al., 2002). YopT therefore be-
longs to the family of phagocytosis blockers. (4) YopE is
a GTPase activating protein (GAP) that inactivates Rho
GTPases by hydrolyzing their bound GTP into GDP (Black
and Bliska, 2000). Although its major effect is also to arrest
the cytoskeletal rearrangements leading to phagocytosis,
it has also been shown to prevent the release of IL-1b
(Schotte et al., 2004).
Shigella is a paradigm of macrophage killing. It disrupts,
invades, and causes the inflammatory destruction of the
human colonic and rectal epithelium. The current patho-
genic scheme indicates that because of a plasmid-born
pathogenicity island encoding a TTSS and its dedicated
effectors, the bacteria, after initial translocation through
M cells, invade the epithelial lining baso-laterally and dis-
seminate by an actin-dependent cell-to-cell spreading
process (Cossart and Sansonetti, 2005). After transloca-
tion across the follicle-associated epithelium, Shigella
causes apoptosis of subepithelial macrophages (Zychlin-
sky et al., 1992) through IpaB-mediated activation of cas-
pase-1 (Hilbi et al., 1998). This mechanism also triggers
early mucosal inflammation through the release of mature
IL-1b and IL-18 as a result of caspase-1-mediated cleav-
age of their precursors. This inflammatory process is
a double-edge sword with regard to successful Shigella
infection. On the one hand, it disrupts the epithelial barrier
and facilitates bacterial invasion; on the other hand, it
accounts for bacterial killing (Perdomo et al., 1994b; San-
sonetti et al., 1995, 2000).Immunity 26, February 2007 ª2007 Elsevier Inc. 153
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phages. This species establishes another paradigm of in-
teraction (Schlumberger and Hardt, 2006). The initial step
is similar to Shigella, where the SipB effector, encoded
by the spi1 pathogenicity island (PAI), causes macrophage
apoptosis through activation of caspase-1 (Monack et al.,
2000). The subsequent steps are considerably different,
with a switch in strategy in which bacteria eventually ‘‘ac-
cept’’ phagocytosis by resident macrophages of the
dome and the surrounding area but remodel their phago-
some in such a way that Salmonella can reside and grow
in a self-made intracellular compartment, the Salmonella-
containing vacuole (SCV) whose structure and dynamic
is controled by effectors secreted in the cytoplasmic side
of the vacuole by the TTSS encoded by spi2, another major
PAI of Salmonella that permits survival and dissemination
of the microorganism (Holden, 2002). The Salmonella-en-
coded protein SifA plays an important role in mediating
the recruitment of vesicles and to increase the amount of
SCV membrane, thereby avoiding its rupture and transition
to a lysosome. This strategy is key to the capacity of Sal-
monella to further disseminate in its infected host and
cause septicaemia, reinforced, in Salmonella typhi, by its
expression of a capsule, the Vi antigen.
Dampening Inflammatory Signals
Beside those involved in the cytoskeletal alterations that
suppress phagocytosis, two other Yersinia Yops are ded-
icated to dampening the innate immune response. YopP/J
is a cysteine protease that disrupts the MKK and NF-kB
pathways, possibly, as initially thought, by acting as a deu-
biquitinase, or by inducing desumoylation. It inhibits proin-
flammatory responses by downregulating expression of
cytokines such as TNF-a, but at the same time also in-
duces apoptosis of infected macrophages (Mills et al.,
1997; Monack et al., 1997; Ruckdeschel et al., 1997). Re-
cent data, however, indicate that YopP/J is an acetyl-
transferase that modifies the critical serine and threonine
residues of MAPK6 and I-KKb, thereby blocking their
phosphorylation, and thus their capacity to activate the
MAPK and NF-kB pathways, respectively. This leads to
dramatic anti-inflammatory and proapoptotic effects (Mu-
kherjee et al., 2006). YopM is a leucine-rich repeat (LRR)-
containing protein that localizes into the nucleus. It has
been shown to form a complex with ribosomal S6 kinases
RSK1 and PRK2 with unknown substrates, the signifi-
cance of these observations being yet unclear (Skrzypek
et al., 1998). YopM belongs to a large family of LRR pro-
teins whose homologs are present in other gram-negative
pathogens.
In the case of Shigella spp., in addition to their extracel-
lular recognition by TLRs, intracellular bacteria activate
the Nod1-dependant signaling cascade, leading to activa-
tion of the NF-kB and JNK inflammatory pathways. This is
an essential step because epithelial cells acquire the ca-
pacity to express proinflammatory cytokines and chemo-
kines such as IL-8 (Girardin et al., 2003), thereby recruiting
PMNs that disrupt the epithelial barrier. It seems that the
pathogenicity of Shigella has been ‘‘forged’’ by the neces-154 Immunity 26, February 2007 ª2007 Elsevier Inc.sity to induce some level of inflammation to disrupt the ep-
ithelial barrier, without being rapidly killed by PMNs. The
capacity of bacteria to quickly penetrate into epithelial
cells may be part, but not all, of this protective strategy.
Another wave of effectors proteins, the Osps and IpaHs,
are also injected through theShigella TTSS. Some of these
effectors are regulators of the innate immune response.
OspG is a kinase that binds a limited set of ubiquitinated
E2 (ubiquitin-conjugating) enzymes, particularly those in-
volved in the degradation of I-kB, and blocks their func-
tion, thereby preventing translocation of the NF-kB com-
plex in the nucleus (Kim et al., 2005). OspG is a potent
anti-inflammatory molecule, an unexpected finding in Shi-
gella pathogenesis. OspF is a dual phosphatase that rea-
ches the host cell nucleus and dephosphorylates Erk1/2
and P38, thereby leading to the dephosphorylation of His-
tone 3 on serine 10 and impairing accessibility of the NF-
kB complex on a series of promoters, including IL-8. This
is a newly recognized form of epigenetic regulation carried
out by bacteria. At the innate stage of the response, OspF
is a potent regulator of PMN transmigration through the
epithelial barrier (Arbibe et al., 2007). It therefore seems
that OspF and OspG are potent regulators of the innate re-
sponse at the level of the mucosal barrier, where the Shi-
gella infectious process essentially occurs. A major func-
tion is likely to be the downregulation and shaping of the
immune response elicited by the combination of the Nod
and TLR-mediated signals at a level that prevents bacte-
rial death, thereby allowing successful mucosal coloniza-
tion and invasion.
Bacterial manipulation of ubiquitination of essential
molecules in the signaling and regulatory processes shap-
ing up immune responses will soon become a recurrent
theme in tolerance and pathogenesis induction. One
should stress that viruses (such as the g-herpes family)
have been known to express proteins that either modify
ubiquitination processes or are themselves ubiquitin li-
gases. As part of the viral immunoevasion strategy, the
mK3, K3, and K5 gene products from the g2 group of
g-herpes viruses belong to a family of membrane-
associated ubiquitin E3 ligases that decrease cell-surface
expression of major histocompatibility complex class I
molecules and other immunoreceptors including intercel-
lular adhesion molecule-1, CD86, and CD1d (Lehner et al.,
2005).
Inactivating Immune Cells
Certain bacterial virulence factors can inflict global dam-
age on immune reactivity by targeting hematopoietic cells
for inactivation or destruction. By crippling the essential
initiators and effectors of immune responses (macro-
phages, dendritic cells, and lymphocytes), toxins can dra-
matically modify the host capacity to resist bacterial
invasion.
The Listeriolysin O (LLO) of Listeria monocytogenes rep-
resents a paradigm for the role of bacterial hemolysins as
membrane-damaging toxins altering immune responses.
LLO causes membrane lysis, allowing L. monocytogenes
to escape into the cell cytoplasm and to spread from
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tion foci also deletes immune cells at the early stage of the
infectious process by a mixed caspase-dependent and
-independent process (Carrero et al., 2004a). This process
involves Type I interferons, which enhance the susceptibil-
ity of macrophages and activated lymphocytes to LLO-in-
duced apoptosis (Carrero et al., 2004b; Stockinger et al.,
2002). Mice lacking the Type I interferon receptor are re-
sistant to L. monocytogenes infection (Auerbuch et al.,
2004), and Type I interferons enhance susceptibility of
mice to L. monocytogenes infection (O’Connel et al.,
2004). These results indicate that L. monocytogenes has
harnessed an innate pathway required to eliminate infect-
ing viruses to promote its successful infection. It becomes
essential to clarify the immunological consequences of
cell death during bacterial infection. By increasing the sus-
ceptibility of macrophages and activated lymphocytes to
death, L. monocytogenes interferes primarily with the
IFN-g axis that is essential for priming innate responses
(macrophage activation) and orienting adaptive immunity
(Th1 polarization) essential for complete pathogen eradi-
cation. As indicated above, immune cell apoptosis has
also been described in infection by Shigella, S. pneumo-
nia, S. aureus (a-toxin),C. difficle,B. anthracis, and Y. pes-
tis (Carrero et al., 2006). Apoptosis of immune cells may in-
directly regulate innate responses because ingestion of
apoptotic bodies by macrophages potentially downregu-
lates inflammation via release of TGF-b, PGE2, and PAF
(Fadok et al., 1998).
Bacterial toxins may also induce global signaling shut-
down. The tripartite anthrax toxin produced by pathogenic
strains of Bacillus anthracis has multiple effects on in-
fected cells (Baldari et al., 2006). This three-component
toxin complex consists of a protective antigen (PA) and
two toxins, edema factor (EF) and lethal factor (LF). PA
complexes with either LF or EF and mediates their pene-
tration into host cells. Although the early stages of infec-
tion occur in the lymph nodes draining the contamination
focus, the host fails to mount an effective immune re-
sponse because of LF and EF acting as potent suppres-
sors of cellular activation and proliferation. LF is a highly
specific zinc metalloprotease that inactivates the family
of mitogen-activated protein kinase kinase (MAPKK) on
their N termini (Duisbery et al., 1998), eventually causing
cell death. EF is a calmodulin-dependent adenylate cy-
clase that induces massive production of cAMP in intoxi-
cated cells (Leppla, 1982). A major downstream effect is
inhibition of the mitogen-activated protein and stress ki-
nase pathways (MAPK). Together, LF and EF cooperate
and possibly synergize in acting on the MAPK/stress ki-
nases pathways, thereby downregulating major transcrip-
tional pathways (NFAT and AP-1) involved in the triggering
and modulation of innate and adaptive immune cytokine
responses. These toxins act on PMN cells to inhibit
NADPH oxidase activity, thereby impairing their bacteri-
cidal capacities (Crawford et al., 2006). In addition to this
potentially deleterious effect on early control of bacterial
spread by neutrophils, anthrax toxins also potentially
dampen the innate and adaptative response by killingphagocytes (Park et al., 2002) and by interfering with anti-
gen-presenting DCs and T cells (see below).
Subverting DC Functions
DCs orchestrate the innate and adaptive immune re-
sponses and play a central role in properly interpretating
signals that maintain nonresponsiveness (tolerance) ver-
sus those that should be decoded to trigger a neutralizing
immune response against pathogens. PRRa are abun-
dantly expressed by DC, and DC activation by PAMPs
leads to their maturation, a complex process that results
in antigen presentation, increased expression of costimu-
latory molecules, and initiation of an adaptive immune
response. Activated DCs produce chemokines and ‘‘ho-
meostatic’’ cytokines (including IL-7 and IL-15) that recruit
and potentially maintain innate and adaptive lymphocytes.
PRR-induced DC maturation can instruct distinct pro-
grams of T helper cell differentiation depending on the
type of ‘‘polarizing’’ cytokines (IL-12 for Th1, IL-10 for
Tr1, IL-6 for Th17) that are produced (Agrawal et al.,
2003). Finally, TLR triggering plays a key role in discrimi-
nating between tolerance and immunity, by regulating an-
tigen processing after phagocytosis at the level of phago-
some maturation (Blander and Medzhitov, 2004). In this
way, only TLR-associated pathogenic antigens (but not
non-TLR-associated coingested self-antigens) reach the
MHC class II compartment to finally prime immune re-
sponses (Yarovinsky et al., 2006). Coordination between
PRR signals and DC maturation must therefore be tightly
controlled in order to maximize immunity yet maintain tol-
erance. As such, pathogens have multiple opportunities to
subvert the immune response at the level of DC functions
in order to perturb the immunity tolerance balance.
Several pathogens appear to interfere with the capacity
of DC to efficiently stimulate T cells, either through down-
regulation of their antigen presenting or costimulatory
functions. Although B. anthracis tripartite toxin can selec-
tively deplete macrophages, it fails to lyse DCs but never-
theless affects several aspects of their immune priming
function. For example, LF inhibits expression of inducible
CD80 and CD86 antigens that are essential T cell costimu-
latory molecules (Agrawal et al., 2003). Similarly, Borde-
tella bronchiseptica adenylate cyclase toxin (ACT) and
TTSS synergize to block induction of CD40 and CD86 ex-
pression during DC maturation (Siciliano et al., 2006). The
19 kDa protein from Mycobacterim tuberculosis affects
MHC class II expression through modulation of the class
II trans-activator CIITA and via direct effects on the MHC
class II promoters (Pennini et al., 2006).Salmonella SifA in-
terferes with intracellular vesicle movement and when ex-
pressed in DC, SifA abrogates the capacity of DC to pres-
ent exogenous antigens to T cells (Petrovska et al., 2004).
Illustrating another strategy elaborated by pathogens to
reorient the immune response, Helicobacter pylori can
switch on and off the Lewis antigen (Le) motif associated
to its LPS. The Le+ LPS is able to bind to the C-type lectin
DC-SIGN present on gastric DCs, with resultant down-
regulation of Th1 polarization of the immune response
(Bergman et al., 2004).Immunity 26, February 2007 ª2007 Elsevier Inc. 155
Immunity
ReviewDC cytokine production plays a critical role in T helper
cell differentiation, and through development of Th1-Th2
versus regulatory T cell subsets, are critical to deciding
between the maintenance of tolerance verus the engage-
ment toward ‘‘full-blown’’ immunity. Recent advances in
our understanding of cytokine signals that induce the in-
flammatory Th17 add an additional layer to this complexity
(Tato and O’Shea, 2006). Pathogens have clearly appreci-
ated the critical role of DC in Th differentiation and have
devised several strategies to manipulate this process to
their advantage.
Although the main escape mechanism of Mycobacte-
rium tuberculosis is to survive inside host cells aided by
a complex of cell wall glycolipids, it now is clear that it
also suppresses the innate response by downregulating
IL-12 and inducing IL-10 expression (Nau et al., 2002). A
region of its genome absent in Mycobacterium bovis,
BCG, encodes a secretion system responsible for IL-12
suppression (Stanley et al., 2003). A 19 kDa lipoprotein
(LpqH) that signals through TLR2 may be the effector (For-
tune et al., 2004). Although mycobacterial recognition by
DC-SIGN was proposed to elicit IL-10 production (Geij-
tenbeek et al., 2003), recent data suggest otherwise (Tail-
leux et al., 2005). The end result of M. tuberculosis DC
infection is a shift in T cell differentiation from Th1 to Tr1,
which, by virtue of the strong IL-10 production by the lat-
ter, sustains an immunosuppressive state. This DC sub-
version by M. tuberculosis appears relevant clinically be-
cause IL-10-producing Tr1 cells are found in infected
patients (Boussiotis et al., 2000).
Yersinia pestis directly infects DC (Marketon et al., 2005)
and dampens DC IL-12 and TNF-aproduction via an IL-10-
dependent mechanism (Brubaker, 2003). IL-10 induction
is achieved by the LcrV antigen in a CD14-TLR2-depen-
dent manner (Sing et al., 2002). Interestingly, LcrV is the
best protective antigen againstY. pestis, possibly because
it is able to elicit neutralizing antibodies that block the func-
tion of Yop delivery (Anderson et al., 1996). An LcrV variant
(lacking amino acid residues 271 to 300) with reduced ca-
pacity to induce IL-10 secretion has shown promise as
a vaccine for plague (Overheim et al., 2005).
Brucella invade DCs and replicate, as in macrophages,
in an ER-derived compartment, because of its expression
of a type IV secretory apparatus. The consequence of DC
invasion is the inhibition of DC maturation leading to
a downmodulation of cytokine secretion and antigen pre-
sentation. This inhibitory effect is attributed to the expres-
sion of twoBrucella effector proteins that act on TLR path-
ways (J.-P. Gorvel, personal communication).
Another example of DC subversion is provided by
Francisella tularesis. Although the bacterial effector is
not identified, DC from F. tularensis-infected mice pro-
duce reduced amounts of IL-6 but increased amounts of
TGF-b (Bosio and Dow, 2005), thus favoring development
of CD25+ regulatory T cells, which ‘‘naturally’’ suppresses
Th1 and Th2 pathways. In all these cases, Th1 differentia-
tion (with subsequent loss of the signature cytokine IFN-g)
is suppressed, thereby providing a potentially ‘‘subinflam-
matory’’ niche for pathogen persistence.156 Immunity 26, February 2007 ª2007 Elsevier Inc.Trophic cytokines (including IL-7 and IL-15) that are the
sentinels of lymphocyte homeostasis may be induced
upon TLR stimulation of DC and macrophages (Zhang
et al., 1998). These cytokines may play an important role
in maintaining ‘‘innate’’ lymphocytes (NK, NKT, gd T cells)
at the site of infection and/or inflammation. In addition to
the targeted effects of Y. pestis on IL-10, another level of
immunosuppression is largely achieved by YopM that
can decrease expression of IL-15 and IL-15Ra and
thereby cause a global depletion of NK cells (Kerschen
et al., 2004). The 19 kDa lipoprotein from M. tuberculosis
also suppresses IL-15 levels in infected DC. NK cells re-
cruited to inflammatory lymph nodes have been shown
to augment Th1 polarization to nominal antigen (Martin-
Fontecha et al., 2004), whereas NK cell depletion inB. per-
tussis infection results in disseminated disease secondary
to poor Th1 T cell differentiation (Byrne et al., 2004).
Although triggering of TLR plays a key role in DC matu-
ration through increased expression of costimulatory mol-
ecules and differential secretion of stimulatory cytokines,
the signaling pathways that encode these biological ef-
fects are only poorly understood. Stimulation of TLRs re-
cruit TIR domain-containing adaptors (MyD88, TIRAP)
that provide a scaffold for kinases (IRAK), TRAFs, and
transcription factors (IRFs) that ultimately lead to gene
transcription through NF-kB and MAPK pathways (Akira
et al., 2006). Recent evidence suggests that cytokine ex-
pression in DC is controlled by differential TRAF associa-
tion to TIR-containing adaptors (Hacker et al., 2006). In
particular, TRAF3 was found to be essential for induction
of type I interferons and IL-10 and appeared to counter-
balance TRAF6 signaling. Regulation of the MAPK path-
way targets JNK, p38, and ERK are also critically involved
in determining DC cytokine secretion profiles after TLR2
triggering in response to yeast zymosan. JNK and p38 ac-
tivation was correlated with strong IL-12 production,
whereas ERK stimulation induced c-Fos that acted to sup-
press IL-12 and upregulate IL-10 (Dillon et al., 2006). The
capacity for distinct PAMP to modulate these intracellular
signaling pathways from TLR could provide an additional
means for pathogens to subvert DC function.
Targeting Adaptive Immune Effectors
S. aureus strains often express several superantigens
(such as staphylococcal enterotoxins and the toxic shock
syndrome toxin-1, TSST-1) that cause both systemic ef-
fects such as emesis and diarrhea but also severe malaise
and possibly shock. This is largely due to brisk and over-
whelming release of proinflammatory cytokines. Superan-
tigens bind the exterior surface of the MHC class II protein
on the surface of antigen-presenting cells, thus linking it to
T cell receptors (TCR) on the surface of a T helper cell.
Binding occurs without need for the class II molecule to
present its cognate antigenic peptide. Each enterotoxin
recognizes a particular subset of variable Vb chains of
TCR, establishing its Vb signature. Up to 30% of T cells
can be activated to proliferate, thereby causing the mas-
sive cytokine release characteristic of superantigen stim-
ulus (Lewelyn and Cohen, 2002). Superantigen-specific
Immunity
ReviewT cells stop proliferating in response to antigens normally
presented by MHC class II molecules, causing a situation
of anergy that strongly impairs production of antibodies,
particularly of those directed against the superantigen it-
self (Lussow and MacDonald, 1994). In addition, S. aureus
Protein A can bind to the VH3 region adjacent to the anti-
gen-binding domain of IgM molecules exposed on the
surface of innate-like B1 lymphocytes. The latter are a par-
ticular category of B cells that produce natural antibodies
and are capable of accelerated clonal expansion in the
case of a microbial agression (Goodyear and Silverman,
2004). Protein A binding to B1 cells leads to their prolifer-
ation and apoptosis with subsequent deletion in lymphoid
organs. Superantigens strongly alter the normal pattern of
immune responses, particularly resulting from clonal dele-
tion of B lymphocyte (Lewelyn and Cohen, 2002). These
superantigen effects on T and B cells largely explain the
frequent relapse of staphylococcal toxic shock syndrome.
Similarly, Streptococcus pyogenes produces superanti-
gens that are strongly related to S. aureus superantigens
and cause similar systemic symptoms and pathological
effects, thus probably causing similar corruption of im-
mune responses (Lewelyn and Cohen, 2002). Superanti-
gens offer excellent models to study the mechanisms of
subversion of the immune system by bacteria, particularly
the interface between an excess of innate response en-
gaging a defect in the adaptive response. This interesting
combination is clearly at the heart of pathogenic pro-
cesses evolved by microorganisms.
Helicobacter pylori VacA inhibits the activation and pro-
liferation of T lymphocytes in vitro (Gebert et al., 2003) by
inducing a G1/S cell-cycle arrest. VacA interferes with in-
terleukin-2 (IL-2) production at the level of the Ca2+ cal-
modulin-dependent phosphatase calcineurin, which is re-
quired for NFAT-mediated IL-2 transcription. In addition,
VacA activates intracellular signaling through the mito-
gen-activated protein kinases MKK3 and MKK6 and p38
and the Rac-specific nucleotide exchange factor, Vav
(Boncristiano et al., 2003). As a consequence of this aber-
rant Rac activation, actin polymerization is disordered, re-
sulting in ineffective T cell immune response. In this way,
VacA mimicks the activity of immunosuppressive drugs
by inducing a local immune suppression, possibly leading
to chronic colonization of this gastric niche by H. pylori.
Bacillus anthracis-derived LF and EF have also been
shown, at sublethal dose in mice, to suppress TCR-medi-
ated lymphocyte activation (Comer et al., 2005). Treat-
ment with lethal doses of LF blocks several kinase-signal-
ing pathways that participate in T cell receptor-mediated
activation of T cells. Phosphorylation of the extracellular
signal-regulated kinase and the stress-activated kinase
p38 was decreased. In addition, phosphorylation of the
serine/threonine kinase AKT and of glycogen synthase ki-
nase 3 was inhibited in T cells in mice injected with LF.
It is likely that many bacterial pathogens can directly tar-
get cellular effectors of the adaptive immune system. This
may be achieved by secreting toxins (as detailed above) or
by blocking lymphocyte-signaling pathways through en-
gagement of an inhibitory surface receptor. This strategyis used by Neisseria gonorrhoeae, whose Opa surface
proteins engage CEACAM1 (CD66a), thereby leading to
an impairment of the host humoral response (Pantelic
et al., 2005).
Future Perspectives
Recent attempts at understanding the molecular and cel-
lular mechanisms of infectious diseases has placed a
central focus on the cell biology of the host-pathogen in-
terface, thereby providing new opportunities for interac-
tions between microbiologists and immunologists. After
studies utilizing cellular models (epithelial cells, fibro-
blasts), cellular microbiologists recognize that immune
cells are primary targets in the course of an infection. Like-
wise, immunologists are realizing the importance of a de-
tailed knowledge of the microbiological world to better
understand the diversity and constraints against which
the immune system has evolved. The time is ripe to bridge
microbiology and immunology once again. The recent ex-
plosion of knowledge in innate immunity that has occurred
at the border of microbiology and immunology provides
an excellent example that hopefully forecasts an ongoing
trend. The potential synergy provided by concerted col-
laborations between microbiologists and immunologists
will undoubtedly speed up the development of new tools
to control infectious diseases, including the design of in-
novative drugs, the discovery of new target antigens,
and the development of novel immuno-adjuvants that
may lead to better vaccines.
We suggest that this concerted effort should be specif-
ically applied to the following areas. (1) Better character-
ization of the major functions of microbial effectors. First,
the ubiquitination pathways appear as a general target
for regulation. YopP/J and OspG are the first of a growing
list of TTSS effectors that have elected ubiquitination of
regulatory molecules as a way to affect immune re-
sponses. The second emerging theme is pathogen-driven
epigenetic regulation of gene expression. This is exempli-
fied by Shigella OspF that can manipulate the histone
code of target cells, resulting in dampening of epithelial in-
filtration by PMN and possible shutting down of the Th1 re-
sponse. There is no doubt that other examples will soon
appear that illustrate how bacterial pathogens employ
sophisticated strategies to ensure their survival. These
examples do raise the question of the origin of the TTSS
effectors. At which stage and against which type of host
immune systems has this pool of genes been constituted;
how did it diffuse into pathogens and under what circum-
stances? Current metagenomic approaches should help
trace these genes. (2) Better characterization of the host
sensors involved in the discrimination between ‘‘physio-
logical’’ and ‘‘pathological’’ inflammation. The NALP3-in-
flammasome is a protein complex stimulating caspase-1
activation to promote the processing and secretion of
proinflammatory cytokines (Ogura et al., 2006). Recently,
NALP3 was shown to activate caspase-1 in response to
uric acid released extracellularly by cells undergoing ne-
crosis (Martinon et al., 2006). This is a major contribution
that links PAMPs and ‘‘natural’’ host molecules in a globalImmunity 26, February 2007 ª2007 Elsevier Inc. 157
Immunity
Reviewconcept of danger signals released by infecting microbes
or altered cells. These danger signals will undoubtedly be
increasingly recognized in the future. NALP3, for instance,
monitors K+ depletion in cells, such situations being trig-
gered by paracrine signals such as ATP release by
stressed cells (Mariathasan et al., 2006), or some micro-
bial toxins, like hemolysins, that alter membranes and ac-
tivate potassium efflux pumps (Gurcel et al., 2006). (3) Es-
tablishing relevant animal models. It will be essential to
more clearly define how these effectors affect the adap-
tive immune response, either indirectly through the alter-
ation of the innate response or by acting directly on the ef-
fector cells of the adaptive response (antigen presentation
cells and/or lymphocytes). This question is already being
addressed in many model systems, but requires precise
tools and detailed analysis. Novel approaches that use hu-
manized mouse models based on tissue xenografts (that
can provide the substrates for certain human pathogens
and allow for development of a functional innate and
adaptive human immune system) may provide a more ap-
propriate setting for studying and understanding the im-
munological de´tente between the host and the pathogen.
These questions will not be solved without defining the
temporo-spatial conditions of delivery of the bacterial ef-
fectors, and this is particularly true for those that are di-
rectly injected into cells. Another key issue is the nature
of the actual target cells in vivo. This will need major
investment in the development of techniques that allow
visualization, possibly in real time (better in vivo than ex
vivo), the cells that have actually been targeted by a given
effector, as has been recently observed in Yersinia-
infected mice (Marketon et al., 2005).
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